Showing results (761-770 of 787) with videos related to

Sort By:
Pageof 79
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
The Journal of Molecular Diagnostics : JMD|July 11, 2006
Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histologyRyan L Parr, Gabriel D Dakubo, Keith A Crandall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersCatherine Demos, Jermaine Brown, Brian Ngo, et al.
Journal of Proteome Research|October 16, 2010
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assaysA Prakash, T Rezai, B Krastins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculatorsRobert K Nam, Michael W Kattan, Joseph L Chin, et al.
Clinical Chemistry|October 5, 2012
Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor MarkersGyörgy Sölétormos, Michael J Duffy, Daniel F Hayes, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2022
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control studyAntigona Ulndreaj, Davor Brinc, Mehmet Altan, et al.
Clinical Chemistry|March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancersCatharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
Biological Chemistry|June 28, 2006
A comprehensive nomenclature for serine proteases with homology to tissue kallikreinsAke Lundwall, Vimla Band, Michael Blaber, et al.
Journal for Immunotherapy of Cancer|May 31, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanomaZena N Willsmore, Lucy Booth, Akshay Patel, et al.
Pageof 79